Please login to the form below

Not currently logged in
Email:
Password:

Marino Garcia joins Synergy Pharmaceuticals

He has experience in gastrointestinal market at Aptalis

Synergy GomezSynergy Pharmaceuticals has appointed Marino Garcia to the newly-created role of senior VP, corporate development.

Garcia joins the New York-based gastrointestinal specialist from Aptalis Pharma, which also focused on the gastrointestinal market, as well as cystic fibrosis.

This experience will be beneficial as Garcia looks to play a significant role in Synergy's strategic corporate planning and business development activities as it moves several products to late-stage development.

“I am excited to be joining Synergy,” said Garcia. “This company has quickly transitioned from a small biotech start-up to a late-stage drug development company with major clinical milestones in the near term.”

Prior to his time at Aptalis Garcia was VP of US commercial operations and new product development at Aspreva Pharmaceuticals. He also has experience at Lilly and Pfizer.

19th March 2014

From: Sales

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics